ChromaDex Receives Retraction and Apology from Author of Inaccurate Article
ChromaDex Corp. (Irvine, CA), a leading provider of proprietary science-backed technologies and analytical services for dietary supplement, food and beverage, skincare, sports nutrition and pharmaceutical products, announced that an article by Bleecker Street Research published on Seeking Alpha on June 20, 2016 has been removed and replaced with an apology from the author.
The following message has replaced the article:
“This article has been removed from the site. The below is a message from the author.
Bleecker Street Research is removing its article on Barry Honig, ChromaDex and Pershing Gold. After further research we believe that the statements were not supported and the premise of the article was allegedly factually inaccurate. Bleecker Street would like to apologize to ChromaDex, Pershing Gold, and Barry Honig for an allegedly misleading article and to immediately set the record straight for our readers who should not rely on certain aspects upon the withdrawn article or statements of the author therein. To our readers: In the future we will document everything even more carefully.”
ChromaDex published a press release on June 20, 2016 refuting the allegations. Additionally, Frank Jaksch Jr., founder and CEO of ChromaDex, published a shareholder letter on June 24, 2016 debunking the multiple false allegations, which can be found on the investor relations section of www.chromadex.com.
